Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Trojano

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Genes and Immunity|May 23, 2008
Variations of the perforin gene in patients with multiple sclerosisG Cappellano, E Orilieri, C Comi, et al.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 15, 2011
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological SocietyA Ghezzi, L M E Grimaldi, M G Marrosu, et al.
Journal of the Neurological Sciences|July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatmentM Trojano, F Pellegrini, D Paolicelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 11, 2016
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityF Patti, S Messina, C Solaro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitudeJ Lechner-Scott, B Spencer, T de Malmanche, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Multiple sclerosis registries in Europe - An updated mapping surveyA Glaser, A Stahmann, T Meissner, et al.
Acta Neurologica Scandinavica|September 14, 2012
Fluctuations of MS births and UV-light exposureF Verheul, J Smolders, M Trojano, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Genes and Immunity|May 23, 2008
Variations of the perforin gene in patients with multiple sclerosisG Cappellano, E Orilieri, C Comi, et al.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 15, 2011
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological SocietyA Ghezzi, L M E Grimaldi, M G Marrosu, et al.
Journal of the Neurological Sciences|July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatmentM Trojano, F Pellegrini, D Paolicelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 11, 2016
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityF Patti, S Messina, C Solaro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitudeJ Lechner-Scott, B Spencer, T de Malmanche, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Multiple sclerosis registries in Europe - An updated mapping surveyA Glaser, A Stahmann, T Meissner, et al.
Acta Neurologica Scandinavica|September 14, 2012
Fluctuations of MS births and UV-light exposureF Verheul, J Smolders, M Trojano, et al.
Pageof 11